Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1201305019 | Terazosin hydrochloride 5mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1214304011 | Terazosin hydrochloride 5mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3471791010 | Terazosin hydrochloride 5 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3471792015 | Product containing terazosin hydrochloride 5 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3490141016 | Product containing terazosin hydrochloride 5 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3568601014 | Product containing only terazosin hydrochloride 5 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3568602019 | Product containing only terazosin hydrochloride 5 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3683395013 | Terazosin 5 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3683396014 | Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3683397017 | Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Is a | Product containing alpha-1 adrenergic receptor antagonist (product) | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Is a | Terazosin hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has active ingredient | Terazosin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has active ingredient | Terazosin hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Is a | Product containing terazosin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has active ingredient | Terazosin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral capsule | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has active ingredient | Terazosin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has basis of strength substance (attribute) | Terazosin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Is a | Terazosin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has precise active ingredient | Terazosin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule | Is a | Terazosin only product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR